Myriad Genetics, Inc. (MYGN)

USD 7.56

(6.03%)

Long Term Debt Summary of Myriad Genetics, Inc.

  • Myriad Genetics, Inc.'s latest annual long term debt in 2022 was 130.9 Million USD , up 65.07% from previous year.
  • Myriad Genetics, Inc.'s latest quarterly long term debt in 2023 Q2 was 186.8 Million USD , up 27.51% from previous quarter.
  • Myriad Genetics, Inc. reported annual long term debt of 79.3 Million USD in 2021, down -64.72% from previous year.
  • Myriad Genetics, Inc. reported annual long term debt of 224.8 Million USD in 2020, down -3.73% from previous year.
  • Myriad Genetics, Inc. reported quarterly long term debt of 146.5 Million USD for 2023 Q1, up 11.92% from previous quarter.
  • Myriad Genetics, Inc. reported quarterly long term debt of 186.8 Million USD for 2023 Q2, up 27.51% from previous quarter.

Annual Long Term Debt Chart of Myriad Genetics, Inc. (2022 - 1995)

Historical Annual Long Term Debt of Myriad Genetics, Inc. (2022 - 1995)

Year Long Term Debt Long Term Debt Growth
2022 130.9 Million USD 65.07%
2021 79.3 Million USD -64.72%
2020 224.8 Million USD -3.73%
2019 233.5 Million USD 0.0%
2018 233.5 Million USD 2410.75%
2017 9.3 Million USD -90.62%
2016 99.1 Million USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%
2004 - USD 0.0%
2003 - USD 0.0%
2002 - USD 0.0%
2001 - USD 0.0%
2000 - USD 0.0%
1999 - USD 0.0%
1998 - USD 0.0%
1997 - USD -100.0%
1996 100 Thousand USD -80.0%
1995 500 Thousand USD 0.0%

Peer Long Term Debt Comparison of Myriad Genetics, Inc.

Name Long Term Debt Long Term Debt Difference
Aclaris Therapeutics, Inc. 3.07 Million USD -4158.295%
Biodesix, Inc. 35.22 Million USD -271.611%
bioAffinity Technologies, Inc. 1.11 Million USD -11603.509%
Castle Biosciences, Inc. 14.19 Million USD -821.961%
DarioHealth Corp. 24.59 Million USD -432.309%
Exact Sciences Corporation 2.47 Billion USD 94.712%
IDEXX Laboratories, Inc. 622.88 Million USD 78.985%
Illumina, Inc. 1.48 Billion USD 91.209%
Intelligent Bio Solutions Inc. 81.32 Thousand USD -160861.094%
iSpecimen Inc. 29.13 Thousand USD -449264.916%
Standard BioTools Inc. 3.98 Million USD -3186.467%
23andMe Holding Co. 67.84 Million USD -92.94%
Medpace Holdings, Inc. 142.12 Million USD 7.896%
NeoGenomics, Inc. 606.06 Million USD 78.402%
Inotiv, Inc. 399.4 Million USD 67.227%
Psychemedics Corporation 945 Thousand USD -13751.852%
Prenetics Global Limited 867.21 Thousand USD -14994.296%
Precipio, Inc. 106 Thousand USD -123390.566%
RadNet, Inc. 812.06 Million USD 83.881%
Sotera Health Company 2.22 Billion USD 94.113%
Star Equity Holdings, Inc. 1.14 Million USD -11332.314%
Exagen Inc. 19.23 Million USD -580.672%
Natera, Inc. 282.94 Million USD 53.737%
Aspira Women's Health Inc. 1.43 Million USD -9053.846%
Neogen Corporation 888.39 Million USD 85.265%
ICON Public Limited Company 3.66 Billion USD 96.429%
Bionano Genomics, Inc. 7.17 Million USD -1724.39%
CareDx, Inc 28.27 Million USD -362.904%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 79.17 Million USD -65.334%
Guardant Health, Inc. 1.13 Billion USD 88.517%
BioNexus Gene Lab Corp. 98.76 Thousand USD -132439.514%
Fulgent Genetics, Inc. 10.11 Million USD -1194.63%
Sera Prognostics, Inc. 840 Thousand USD -15483.333%
OPKO Health, Inc. 222.03 Million USD 41.045%
Personalis, Inc. 1.23 Million USD -10507.78%
Applied DNA Sciences, Inc. 739.16 Thousand USD -17609.244%
Star Equity Holdings, Inc. 1.14 Million USD -11332.314%
MDxHealth SA 35.56 Million USD -268.069%
Prenetics Global Limited 867.21 Thousand USD -14994.296%
ENDRA Life Sciences Inc. 192.06 Thousand USD -68055.075%
Mainz Biomed B.V. 2.19 Million USD -5861.139%
Trinity Biotech plc 54.65 Million USD -139.52%
Neuronetics, Inc. 59.28 Million USD -120.805%
bioAffinity Technologies, Inc. 1.11 Million USD -11603.509%